[Antithrombotic prophylaxis and treatment in thrombophilic disorders in gynaecology and obstetrics].
Pregnancy and puerperium are physiological thrombophilic condition and risk of venous thromboembolism in pregnancy is 4 - 6 fold higher. This risk is further increased in the presence of the additional risk factors. Inherited thrombophilia is well-defined risk factor for VTE in pregnancy and also can be the risk for obstetrics complications. So that early diagnostic of inherited thrombophilia can result in the decrease of risk of VTE and the obstetrics complications.
Dulícek
P
P
II. interní klinika Lékarské fakulty UK a FN, Oddĕlení klinické hematologie, Hradec Králové, brambpav@fnhk.cz
Penka
M
M
Binder
T
T
Unzeitig
V
V
D000925:Anticoagulants / Q000627:therapeutic use; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000175:diagnosis / Q000517:prevention & control* / Q000628:therapy; D011644:Puerperal Disorders / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D011655:Pulmonary Embolism / Q000209:etiology / Q000517:prevention & control; D012307:Risk Factors; D013923:Thromboembolism / Q000209:etiology*; D019851:Thrombophilia / Q000139:chemically induced / Q000150:complications*; D020246:Venous Thrombosis / Q000209:etiology
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin